266 related articles for article (PubMed ID: 33495197)
21. JNK
Liu J; Wang T; Creighton CJ; Wu SP; Ray M; Janardhan KS; Willson CJ; Cho SN; Castro PD; Ittmann MM; Li JL; Davis RJ; DeMayo FJ
Nat Commun; 2019 May; 10(1):2148. PubMed ID: 31089135
[TBL] [Abstract][Full Text] [Related]
22. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.
Niu Z; Jin R; Zhang Y; Li H
Signal Transduct Target Ther; 2022 Oct; 7(1):353. PubMed ID: 36198685
[TBL] [Abstract][Full Text] [Related]
23. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
24. MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop.
Luo P; Wang Q; Ye Y; Zhang J; Lu D; Cheng L; Zhou H; Xie M; Wang B
J Exp Clin Cancer Res; 2019 Feb; 38(1):74. PubMed ID: 30755230
[TBL] [Abstract][Full Text] [Related]
25. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
26. LUBAC determines chemotherapy resistance in squamous cell lung cancer.
Ruiz EJ; Diefenbacher ME; Nelson JK; Sancho R; Pucci F; Chakraborty A; Moreno P; Annibaldi A; Liccardi G; Encheva V; Mitter R; Rosenfeldt M; Snijders AP; Meier P; Calzado MA; Behrens A
J Exp Med; 2019 Feb; 216(2):450-465. PubMed ID: 30642944
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells.
Jeong EH; Lee TG; Ko YJ; Kim SY; Kim HR; Kim H; Kim CH
Cell Oncol (Dordr); 2018 Dec; 41(6):663-675. PubMed ID: 30178167
[TBL] [Abstract][Full Text] [Related]
28. The anti-tumor effect of regorafenib in lung squamous cell carcinoma in vitro.
Hu X; Wu LW; Zhang ZY; Chen ML; Li YL; Zhang C
Biochem Biophys Res Commun; 2018 Sep; 503(2):1123-1129. PubMed ID: 29944884
[TBL] [Abstract][Full Text] [Related]
29. A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy.
Wang H; Sun L; Sang Y; Yang X; Tian G; Wang Z; Fang J; Sun W; Zhou L; Jia L; Tsao MS; Shi H; Lin D
Lung Cancer; 2019 Apr; 130():135-142. PubMed ID: 30885334
[TBL] [Abstract][Full Text] [Related]
30. A p53 homologue and a novel serine proteinase inhibitor are over-expressed in lung squamous cell carcinoma.
Wang T; Hopkins DA; Fan L; Fanger GR; Houghton R; Vedvick TS; Repasky E; Reed SG
Lung Cancer; 2001 Dec; 34(3):363-74. PubMed ID: 11714533
[TBL] [Abstract][Full Text] [Related]
31. Co-Expression Network Analysis Identified Genes Associated with Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.
Qin S; Long X; Zhao Q; Zhao W
Cancer Invest; 2020 Jan; 38(1):13-22. PubMed ID: 31770041
[No Abstract] [Full Text] [Related]
32. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
Ming F; Sun Q
Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
34. SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma.
Xu J; Yang S; Gu X; Shen H; Wang L; Xu W; Fang L; Mao Y; Xu L; Chen Y; Fan W; Wang J
Exp Mol Pathol; 2019 Oct; 110():104276. PubMed ID: 31233732
[TBL] [Abstract][Full Text] [Related]
35. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT
Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374
[TBL] [Abstract][Full Text] [Related]
36. Targeting Focal Adhesion Kinase and Resistance to mTOR Inhibition in Pancreatic Neuroendocrine Tumors.
François RA; Maeng K; Nawab A; Kaye FJ; Hochwald SN; Zajac-Kaye M
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971297
[TBL] [Abstract][Full Text] [Related]
37. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
38. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
López-Plana A; Fernández-Nogueira P; Muñoz-Guardiola P; Solé-Sánchez S; Megías-Roda E; Pérez-Montoyo H; Jauregui P; Yeste-Velasco M; Gómez-Ferreria M; Erazo T; Ametller E; Recalde-Percaz L; Moragas-Garcia N; Noguera-Castells A; Mancino M; Morán T; Nadal E; Alfón J; Domènech C; Gascon P; Lizcano JM; Fuster G; Bragado P
Int J Cancer; 2020 Aug; 147(4):1163-1179. PubMed ID: 31943158
[TBL] [Abstract][Full Text] [Related]
39. The kinase TNIK is an essential activator of Wnt target genes.
Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
[TBL] [Abstract][Full Text] [Related]
40. The Ste20 Family Kinases MAP4K4, MINK1, and TNIK Converge to Regulate Stress-Induced JNK Signaling in Neurons.
Larhammar M; Huntwork-Rodriguez S; Rudhard Y; Sengupta-Ghosh A; Lewcock JW
J Neurosci; 2017 Nov; 37(46):11074-11084. PubMed ID: 28993483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]